Journal profile · Urology & Nephrology
European Urology Supplements
ISSN 1569-9056 · eISSN 1878-1500 · Elsevier · NETHERLANDS · Irregular · Founded 2002
European Urology Supplements: impact factor 29.1 (journal website); subscription journal; APC about USD 3,000; review about 16 days (submission to acceptance, publisher); community-reported acceptance: about 50%.
Scope
Aims, scope and focus
European Urology Supplements is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments and Prostate Cancer Treatment and Research, together about 30.9% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the European Association of UrologyElsevier is the publisher of European Urology, the official journal of the European Association of Urology.European Urology publishes peer-reviewed original articles and topical reviews on a wide range of urological problems. Topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, as well as recent advances in techniques, instrumentation, surgery and pediatric urology provide readers with a complete guide to international developments in urology.Published monthly, European Urology is an important journal for all clinicians and researchers in this field.All members of the EAU receive the journal as a benefit of their membership. For more information on the European Association of Urology, please go to: http://www.uroweb.orgOther titles in the European Urology family are:European Urology Open ScienceEuropean Urology FocusEuropean Urology Oncology
From the journal's Aims & Scope
Research area (LetPub): Urology & Nephrology
Editor-in-chief Alberto BrigantiPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 59, Italy 25, United Kingdom 20, Germany 19, Netherlands 14 (192 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Prostate Cancer Diagnosis and TreatmentMedicine11.4%
- Bladder and Urothelial Cancer TreatmentsMedicine10.1%
- Prostate Cancer Treatment and ResearchMedicine9.4%
- Renal cell carcinoma treatmentMedicine7.1%
- Urological Disorders and TreatmentsMedicine6.9%
- Urinary Bladder and Prostate ResearchMedicine6.9%
- Pediatric Urology and Nephrology StudiesMedicine4.9%
- Kidney Stones and Urolithiasis TreatmentsMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 29.1Publisher website ·
- Impact factor (publisher) 2025
- 29.1Publisher website ·
- CiteScore 2026-06
- 2.7LetPub ·
- CiteScore (publisher)
- 45.9Publisher website ·
- SJR 2026-06
- 0.34LetPub ·
- SNIP 2026-06
- 0.84LetPub ·
- h-index
- 28LetPub ·
- h-index
- 50OpenAlex ·
- i10-index
- 556OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher)
- 2,000,000Publisher website ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
16 dayssubmission to acceptance · community reports about 4.2 months
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 4.2 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Acceptance rate (publisher)
- 10%Publisher website ·
- Desk decision
- 12 daysPublisher website ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 23 daysPublisher website ·
- Submission to acceptance
- 16 daysPublisher website ·
- Peer review
- Open peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–10
- Manuscript length
- ≤ 3,500 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Optional
Article types accepted6, with length limits
- brief reportThese manuscripts report novel, exciting urological research. The focus may be basic, translational, or clinical and can include all aspects of urological care.…Length not stated
- original articlemission file as part of the submission. Original articles must be no longer than 2750 words (250 abstract + 2500 body not including what does the studymain text ≤ 2,750 words
- original articlesArticle Types Original ArticlesLength not stated
- perspectiveer one table or one figure are allowed. Perspectives Invited editorials ranging from 500 to 1,000 words where thought leaders in various disciplines provide vis…main text ≤ 1,000 words
- platinum priority editorialsPlatinum Priority EditorialsLength not stated
- review articlee as part of the submission. Word count Review articles must be no longer than 3750 words (250 abstract + 3500 body not including what does the studymain text ≤ 3,750 words
Policy excerpts from the journal's websiteAI use, Authorship, Data availability, Publication ethics, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use The Use of Generative AI and AI-assisted Technologies in Scientific Writing
This policy has been triggered by the rise of generative AI and AI-assisted technologies which are expected to increasingly be used by content creators. The policy aims to provide greater transparency and guidance to authors, readers, reviewers, editors and contributors. Elsevier will monitor this development and will adjust or refine this policy when appropriate. Please note the policy only refer…
Source ↗Publisher website ·- Authorship Authorship Guidelines
Authorship limited to significant contributors; substantial contributors listed as co-authors. Model summary
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made substantial contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the paper (e.g., language editing or medical writing), they should be recognised …
Source ↗Publisher website ·- Data availability Data Access and Responsibility
Authors are expected to freeze datasets at publication and keep copies for up to 5 years. Model summary
For all reports (regardless of funding source) containing original data, at least one named author (e.g., the principal investigator) who is independent of any commercial funder should indicate that she or he ''had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.'' This exact statement will be requested as part o…
Source ↗Publisher website ·- Publication ethics Ethical Approval of Studies and Informed Consent
Formal review and approval by an institutional review board or ethics committee is required for human or animal experimental investigations. Model summary
For human or animal experimental investigations, formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee is required and should be described in the Methods section. For investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. For investigations in human subjec…
Source ↗Publisher website ·- Open access Open Access
Open access options available; see open access information page. Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer Review Process and Publication
Non-native English authors expected to have manuscripts proofread by a professional copyeditor. Model summary
Authors will be sent notifications of the receipt of manuscripts and editorial decisions by e-mail. During the review process, authors can check the status of their submitted manuscript via the online manuscript submission and review system.
Source ↗Publisher website ·- Preprints
Manuscripts must not be previously published or under consideration elsewhere. Model summary
Manuscripts are considered with the understanding that they have not been published previously in print or electronic format and are not under consideration by another publication or electronic medium.
Source ↗Publisher website ·- Trial registration / reporting guidelines CONSORT Flow Diagram and Checklist
Prospective registration of all trials in a public trials registry acceptable to the ICMJE is required as a condition of consideration for publication. Model summary
Manuscripts reporting the results of randomised controlled trials should include a CONSORT flow diagram showing the progress of patients throughout the trial. The CONSORT checklist should also be completed and submitted with the manuscript and can be found at http://www.consort-statement.org/consort-statement/checklist.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- NETHERLANDS
- Frequency
- Irregular
- Founded
- 2002
- ISSN
- 1569-9056
- Electronic ISSN
- 1878-1500
- Society / sponsor
- European Association of Urology
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Urology Supplements
What is the impact factor of European Urology Supplements?
The journal's website gives an impact factor of 29.1 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 2.7, h-index 50.
How long does peer review take at European Urology Supplements?
The publisher reports about 16 days (submission to acceptance); authors report an average review time of about 4.2 months; the community-reported acceptance is “about 50%”; the journal's website gives an acceptance rate of 10%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of European Urology Supplements?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–10; Manuscript length: ≤ 3,500 words; Reference style: AMA; First submission: Free format: the journal's layout is not required; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of European Urology Supplements based?
Of the 192 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (59), Italy (25) and United Kingdom (20). Counted from the institutions listed on the board page; for reference only.
Which databases index European Urology Supplements?
The journal's website lists PubMed; that list has not been checked against each database.
Is European Urology Supplements open access, and what is the APC?
European Urology Supplements is a subscription journal. APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .